Efficacy and safety of combining radiotherapy with first-line chemotherapy and immunotherapy for local advanced/metastatic urothelial cancer: a propensity score matching analysis.
- DOI
- 10.3389/fimmu.2026.1786952
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1786952,
title = {Efficacy and safety of combining radiotherapy with first-line chemotherapy and immunotherapy for local advanced/metastatic urothelial cancer: a propensity score matching analysis.},
author = {Qin J and Zhou H and Li X and Yin H and Deng H and Luo Y and Chen Y and Yin Y and Zhou R and Zhan N and Zheng Y and Zhang T and He W},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1786952},
url = {https://doi.org/10.3389/fimmu.2026.1786952}
}RIS
TY - JOUR TI - Efficacy and safety of combining radiotherapy with first-line chemotherapy and immunotherapy for local advanced/metastatic urothelial cancer: a propensity score matching analysis. AU - Qin J AU - Zhou H AU - Li X AU - Yin H AU - Deng H AU - Luo Y AU - Chen Y AU - Yin Y AU - Zhou R AU - Zhan N AU - Zheng Y AU - Zhang T AU - He W PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1786952 UR - https://doi.org/10.3389/fimmu.2026.1786952 ER -
APA
J, Q., H, Z., X, L., H, Y., H, D., Y, L., Y, C., Y, Y., R, Z., N, Z., Y, Z., T, Z., & W, H. (2026). Efficacy and safety of combining radiotherapy with first-line chemotherapy and immunotherapy for local advanced/metastatic urothelial cancer: a propensity score matching analysis.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1786952
Source records
- pubmed · retrieved 2026-09-25T16:43:21.620Z